Israeli research institutions had 20% more discoveries and inventions in 2012 and 2013 compared to the previous survey in 2010 and 2011, according to Central Bureau of Statistics data published on Tuesday.
The commercial arms of Israel’s research institutions reported 1,438 discoveries and inventions during the previous two years.
The Science Ministry’s National Institute for R&D stated that 70% of these were reported by the country’s universities, while the remainder were reported by hospitals and research institutes.
Of the total number, some 65% were deemed worthy of the protections granted to discoveries and inventions. The universities’ commercial arms reported discoveries and inventions largely in the fields of biotech, medicine, physics, electronics, electro physics, chemistry and nanotechnology. Hospitals primarily reported developments regarding medical devices, while the research institutes focused on agriculture and plant genetics.
The survey was conducted by the statistics bureau on behalf of the Science Ministry.
The research institutions’ commercial arms are responsible for accumulating, marketing and developing the research conducted by their associated institutions. They are also responsible for protecting the knowledge with patents and turning the patents into commercial products.
Some 967 patent requests were submitted by these bodies in 2012 and 2013. Most of the patent requests were filed abroad, and some 80% were submitted by universities.
The increase in inventions and discoveries also had a positive impact on these institutions’ budgets. Intellectual property and royalties brought in some 1.88 billion shekels in 2012, a 12% increase from 2011. Most of the revenue was from Israeli sources,with only 28% coming from foreign bodies. A full 94% of revenues was in the field of medicine.
The commercial arms of these institutions founded 72 startups in Israel and abroad during 2012 and 2013. Some 57 of these startups were founded by the universities.
Want to enjoy 'Zen' reading - with no ads and just the article? Subscribe todaySubscribe now